American BioMed Inc. creates new seat on its board of directors.THE WOODLANDS, Texas--(BUSINESS WIRE)--July 19, 1996--American BioMed Inc. (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). BB:ABMI ABMI Autologous Bone Marrow Infusion ), of The Woodlands, Friday announced that Richard S. Serbin has been appointed to fill the newly created seat on the company's board of directors. This increases the board of directors of the company to six members. Serbin is a registered patent attorney and specialist in FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. law, as well as a registered pharmacist. His qualifications in the health care industry are very diverse in all aspects of management and operations as he has successfully held positions at Johnson & Johnson, Ortho Pharmaceutical In 1941 Ortho Pharmaceutical was founded in Montreal, Canada. The company started with one product and three employees and it was one of the first companies in Canada to make oral contraceptives. , Schering-Plough, Revlon Corp., Lifetime Corp. and other healthcare related companies. At Johnson & Johnson his responsibilities included FDA legal counseling and legal and licensing activities of its Asian Companies. In addition, he served on the board of directors at several of J & J's U.S. and foreign subsidiaries. At Revlon, he helped to implement FDA strategic regulatory policy and represented the company at the first FDA Imminent Hazard Hearing. Serbin was the vice president of Corporate Development for Ortho Pharmaceutical and a member of its board of directors. More recently, he served as president and a member of the board of directors of Bradley Pharmaceutical, founder and chairman of the board for Radius Scientific Inc. and was the founder and general counsel of Bio-Imaging Technologies Inc. of West Trenton, N.J. Company President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , Steven B. Rash stated: "We are very happy to have Mr. Serbin join our board. His legal background pertaining to patents, his working knowledge of the U.S. FDA procedures with his wealth of experience in the healthcare industry will be invaluable to the company in formulating strategic alliances and partnerships which is central to our core business strategy. Mr. Serbin will help American BioMed in fulfilling these strategies to compete in the global healthcare market by formulating those appropriate alliances and partnerships with international healthcare companies whose technologies are synergistic with those of the company in the minimally invasive healthcare field. His contacts in this industry will provide tremendous exposure and opportunities for the company." American BioMed Inc. utilizes state of the art technology to develop, manufacture and market minimally invasive medical, surgical and diagnostic devices which deliver unique advantages through advanced science. Over 25 patents cover its technologies competing in an industry with combined markets estimated at over $10-billion annually. The devices include but ar not limited to the OmniCath(r) atherectomy catheter, as well as the company's nine patented FDA approved unique all-silicone balloon catheters. These consist of thermodilution, embolectomy embolectomy /em·bo·lec·to·my/ (em?bo-lek´tah-me) surgical removal of an embolus. em·bo·lec·to·my n. Surgical removal of an embolus. embolectomy surgical removal of an embolus. and bi-lumen irrigation irrigation, in agriculture, artificial watering of the land. Although used chiefly in regions with annual rainfall of less than 20 in. (51 cm), it is also used in wetter areas to grow certain crops, e.g., rice. , urinary bladder urinary bladder n. A musculomembranous elastic receptacle in the anterior part of the pelvic cavity serving as the temporary storage place for urine. and angioscopy catheters. The OmniStent(tm) and accompanying stent technology is used to support diseased blood vessels Blood vessels Tubular channels for blood transport, of which there are three principal types: arteries, capillaries, and veins. Only the larger arteries and veins in the body bear distinct names. . Other devices such as the company's drug delivery catheters, guidewire microfilter and minimally invasive spinal instruments are also under development. CONTACT: Thomas E. Waite & Associates Inc. 407/324-1606, fax 407/324-0664 |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion